naphthalenediimide has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Butovskaya, E; Cimino-Reale, G; Doria, F; Folini, M; Freccero, M; Nadai, M; Recagni, M; Richter, SN; Tassinari, M; Zaffaroni, N | 1 |
1 other study(ies) available for naphthalenediimide and Prostatic Neoplasms, Castration-Resistant
Article | Year |
---|---|
Down-Regulation of the Androgen Receptor by G-Quadruplex Ligands Sensitizes Castration-Resistant Prostate Cancer Cells to Enzalutamide.
Topics: Androgen Receptor Antagonists; Benzamides; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; G-Quadruplexes; Gene Expression Regulation, Neoplastic; Humans; Imides; Ligands; Male; Naphthalenes; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Signal Transduction; Tumor Cells, Cultured | 2018 |